TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
32 hedge funds and large institutions have $18.8M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Holders
32
Holding in Top 10
1
Calls
$115K
Puts
$6K
Top Buyers
| 1 | +$330K | |
| 2 | +$79.1K | |
| 3 | +$63.5K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$42.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$34.7K |
Top Sellers
| 1 | -$81.1K | |
| 2 | -$67K | |
| 3 | -$14.9K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.3K |
| 5 |
BlackRock
New York
|
-$4.04K |